D-0891-2023 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0891-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on May 30, 2023 and is designated Class II. Reason for recall: Subpotent drug The recall status is terminated (terminated Dec 18, 2023). Affected quantity: 12960 vials.

Recall details

Product Type
Drugs
Report Date
Jul 5, 2023
Initiation Date
May 30, 2023
Termination Date
Dec 18, 2023
Product Quantity
12960 vials

Product description

Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01

Reason for recall

Subpotent drug

Distribution pattern

USA nationwide

Code information

Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0891-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0891-2023. Report a data issue: hello@regdatalab.com.